Parenteral Drug (India) share price
BSE: 524689Pharmaceuticals & Biotechnology
Parenteral Drug (India) Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 1994
Trading suspended since 3 Feb 2025
Last traded ₹2.90 on 21 Aug 2023
Latest announcements
Routine notices left out.
Feb 2025
3 Feb · Suspension of Trading
Trading in the equity shares of Parenteral Drugs (India) Limited (PDPL) shall remain suspended pursuant to intimation received from the Company. As per Resolution Plan the existing equity shares of the Company shall stand delisted with Nil payment. For the detailed corporate announcement submitted by the Company please refer the Exchange website.
Jan 2025
23 Jan · Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
Results for the quarter to Mar 2022
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹1.77 Cr−31.0% on a year ago · +22.9% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Operating profitOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary
- −₹5.88 Cr
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- ₹24 Cr
- Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary
- ₹7.99
- Operating margin
- −331.9%
- Net margin
- 1,343.0%
From revenue to net profit, ₹ crore
- Revenue1.8
- Materials and goods−1.8
- Employee costs−3.8
- Other expenses−2.1
- Operating profit−5.9
- Depreciation−27
- Other income0.0
- One-off items+52
- Finance costs0.0
- Profit before tax19
- Tax+4.6
- Net profit24
Parenteral Drug (India) results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Mar 2022. Results for the quarter to Jun 2022 were due by 14 Aug 2022, 45 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹8.72 Cr, quarter to Jun 2019; lowest ₹1.44 Cr, quarter to Dec 2021Back to profit in the quarter to Mar 2022, ₹24 Cr
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018Q1 | Sep 2018worked out | Dec 2018Q3 | Mar 2019 | Jun 2019Q1 | Sep 2019 | Dec 2019Q3 | Mar 2020 | Jun 2020Q1Filed 25 Aug | Sep 2020 | Dec 2020Q3 | Mar 2021 | Jun 2021Q1 | Sep 2021 | Dec 2021Q3 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 11.7 | 10.8 | 7.9 | 5.1 | 10.6 | 8.9what Revenue from operations, Sep 2018, includes. Not filed on its own: worked out as the nine months to Dec 2018 the company filed, less the three months to Jun 2018 and the three months to Dec 2018. | 10.2 | 2.4 | 8.7 | 7.3 | 7.2 | 8.6 | 2.9 | 4.6 | 2.0 | 2.6 | 2.9 | 2.4 | 1.4 | 1.8 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | 14.0 | 13.5 | 12.8 | 10.6 | 12.8 | 12.7 | 12.4 | 11.7 | 12.7 | 11.0 | 10.2 | 12.7 | 8.7 | 11.1 | 4.9 | −0.8 | 5.6 | 5.6 | 4.7 | 7.7 |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 2.2 | 1.2 | 2.6 | 0.9 | 1.5 | 2.1 | 2.2 | 0.7 | 2.6 | 1.7 | 1.2 | 0.8 | 0.9 | 3.1 | 0.4 | 1.3 | 1.6 | 1.5 | 0.6 | 1.8 |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. Employee costs in the glossary | 3.2 | 3.0 | 3.4 | 4.8 | 5.0 | 4.9 | 4.7 | 5.4 | 4.6 | 4.5 | 4.7 | 5.4 | 4.4 | 4.9 | 3.7 | 1.5 | 3.7 | 3.7 | 3.6 | 3.8 |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. Other expenses in the glossary | 8.6 | 9.3 | 6.9 | 4.9 | 6.4 | 5.8 | 5.5 | 5.6 | 5.5 | 4.8 | 4.3 | 6.4 | 3.4 | 3.2 | 0.8 | −3.6 | 0.2 | 0.5 | 0.4 | 2.1 |
| Operating profit before depreciation | −2.2 | −2.6 | −4.9 | −5.4 | −2.3 | −3.8 | −2.3 | −9.3 | −4.0 | −3.7 | −3.0 | −4.1 | −5.8 | −6.5 | −2.9 | 3.4 | −2.6 | −3.3 | −3.2 | −5.9 |
| Operating margin | −18.8% | −24.4% | −61.9% | −106.0% | −21.6% | −43.2% | −22.2% | −387.6% | −45.6% | −49.8% | −40.9% | −47.7% | −199.6% | −139.3% | −140.9% | 132.0% | −89.9% | −139.1% | −223.6% | −331.9% |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 4.5 | 4.5 | 4.5 | 5.0 | 4.6 | 4.6 | 4.6 | 55.2 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 | 27.2 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | – | 0.3 | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 1.4 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 20.2 | 22.2 | 21.8 | 22.2 | 22.9 | 23.9 | 24.4 | 24.9 | 26.0 | 27.2 | 28.1 | 28.7 | 29.9 | 31.0 | 32.1 | 32.5 | 34.1 | 35.5 | 36.7 | 0.0 |
| Profit before one-off items and taxProfit before one-off items and tax. Profit before tax as it would be without the one-off items below it, as the company states it. Profit before one-off items and tax in the glossary | −27.0 | −29.1 | −30.9 | −32.5 | −29.8 | −32.3 | −31.3 | −88.0 | −34.3 | −35.1 | −35.4 | −36.9 | −40.0 | −41.8 | −39.3 | −33.4 | −41.1 | −43.1 | −44.2 | −33.0 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 52.2 |
| Profit before tax | −27.0 | −29.1 | −30.9 | −32.5 | −29.8 | −32.3 | −31.3 | −88.0 | −34.3 | −35.1 | −35.4 | −36.9 | −40.0 | −41.8 | −39.3 | −33.4 | −41.1 | −43.1 | −44.2 | 19.2 |
| −5.5 | −6.4 | −6.2 | −5.2 | −5.9 | −5.5 | −6.1 | −16.0 | −6.6 | −6.8 | −9.2 | −5.0 | −7.8 | −8.1 | −8.3 | −8.5 | −9.0 | −9.4 | −9.7 | −4.6 | |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | −24.0% |
| Net profit | −21.4 | −22.7 | −24.7 | −27.3 | −23.8 | −26.9 | −25.2 | −72.0 | −27.7 | −28.3 | −26.1 | −31.9 | −32.2 | −33.7 | −31.0 | −24.8 | −32.0 | −33.6 | −34.5 | 23.8 |
| Other comprehensive incomeOther comprehensive income. Gains and losses booked straight to net worth rather than through profit, such as changes in the value of some investments, pension plans and currency translation. Other comprehensive income in the glossary | – | – | – | 0.6 | 0.0 | 0.0 | 0.0 | −0.2 | 0.0 | 0.0 | 0.0 | −0.3 | −0.1 | 0.0 | −0.1 | 0.3 | 0.0 | 0.0 | 0.0 | 0.4 |
| Total comprehensive incomeTotal comprehensive income. Net profit plus other comprehensive income. Total comprehensive income in the glossary | – | – | – | −26.7 | −23.9 | −26.9 | −25.3 | −72.2 | −27.7 | −28.3 | −26.1 | −32.2 | −32.3 | −33.7 | −31.0 | −24.5 | −32.0 | −33.6 | −34.5 | 24.2 |
| Net margin | −182.3% | −209.8% | −311.3% | −531.6% | −225.7% | −302.0% | −248.0% | −3,009.9% | −317.6% | −385.6% | −361.1% | −372.3% | −1,103.8% | −725.5% | −1,520.4% | −966.7% | −1,093.2% | −1,430.2% | −2,393.7% | 1,343.0% |
| Earnings per share | −₹7.18 | −₹7.62 | −₹8.28 | −₹9.15 | −₹8.00 | −₹9.01 | −₹8.47 | −₹24.13 | −₹9.29 | −₹9.50 | −₹8.77 | −₹10.71 | −₹10.81 | −₹11.31 | −₹10.41 | −₹8.33 | −₹10.74 | −₹11.28 | −₹11.58 | ₹7.99 |
Earnings per share in rupees, restated for later splits and bonuses.
The quarters either side of a change of basis do not compare. From the quarter to Mar 2018, the company's revenue for the year to Mar 2018, ₹33 Cr, differs from its quarters added, ₹36 Cr.
10 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
A loss in 9 of the 9 years with results on record
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹33 Cr, differs from its quarters added, ₹36 Cr.
Results for the year to Mar 2022
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue8.5
- Materials and goods−5.5
- Employee costs−15
- Other expenses−3.3
- Operating profit−15
- Depreciation−40
- Other income+0.1
- One-off items+52
- Finance costs−106
- Profit before tax−109
- Tax+33
- Net profit−76
What the company owns
- Plant, investments and other assets₹473 Cr
- Cash and bank₹9 Cr
- Inventory₹1 Cr
What pays for it: net worth and liabilities
- Owed to suppliers₹1,076 Cr
- Borrowings₹116 Cr
Profit and loss
Standalone, ₹ crore, years to March. No results on record for the year to Mar 2016.
| ₹ crore | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 187 | 187 | 177 | – | 55 | 33 | 32 | 32 | 12 | 8 |
| 209 | 204 | 163 | – | 87 | 49 | 50 | 47 | 24 | 24 | |
| Materials and goods bought | 117 | 106 | 79 | – | 26 | 7 | 6 | 6 | 6 | 5 |
| Employee costs | 17 | 19 | 18 | – | 16 | 17 | 20 | 19 | 15 | 15 |
| Other expenses | 75 | 80 | 66 | – | 45 | 25 | 23 | 21 | 4 | 3 |
| Operating profit before depreciation | −22 | −17 | 13 | – | −32 | −16 | −18 | −15 | −12 | −15 |
| Operating margin | −11.8% | −8.9% | 7.6% | – | −58.7% | −48.0% | −55.1% | −46.1% | −96.7% | −176.7% |
| Materials, % of revenueMaterials, % of revenue. Raw materials used and goods bought for resale, adjusted for the change in stock, divided by revenue, times 100. Materials, % of revenue in the glossary | 62.7% | 56.5% | 44.8% | – | 47.6% | 20.5% | 20.2% | 19.8% | 46.5% | 64.3% |
| Employee costs, % of revenueEmployee costs, % of revenue. Salaries, wages and other staff costs divided by revenue, times 100. Employee costs, % of revenue in the glossary | 9.3% | 9.9% | 10.4% | – | 29.3% | 50.6% | 62.3% | 60.3% | 119.3% | 174.0% |
| Other expenses, % of revenueOther expenses, % of revenue. Operating costs besides materials and staff divided by revenue, times 100; with the two above and the operating margin it makes 100. Other expenses, % of revenue in the glossary | 39.9% | 42.6% | 37.2% | – | 81.8% | 76.9% | 72.7% | 66.0% | 30.9% | 38.3% |
| Depreciation and amortisation | 17 | 18 | 24 | – | 19 | 19 | 69 | 17 | 17 | 40 |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | −39 | −34 | −10 | – | −51 | −34 | −87 | −32 | −29 | −55 |
| Other income | – | – | – | – | – | 1 | 1 | 0 | 0 | 0 |
| Finance costs | 42 | 54 | 59 | – | 74 | 86 | 96 | 110 | 125 | 106 |
| Profit before one-off items and tax | −82 | −89 | −70 | – | −125 | −119 | −181 | −142 | −154 | −161 |
| One-off items | – | 34 | 0 | – | 0 | 0 | 0 | 0 | 0 | 52 |
| Profit before tax | −82 | −55 | −70 | – | −125 | −119 | −181 | −142 | −154 | −109 |
| 3 | 4 | −16 | – | −12 | −23 | −33 | −28 | −33 | −33 | |
| Net profit | −85 | −59 | −54 | – | −113 | −96 | −148 | −114 | −122 | −76 |
| Other comprehensive income | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 |
| Total comprehensive income | – | – | – | – | – | −96 | −148 | −114 | −122 | −76 |
| Net margin | −45.5% | −31.4% | −30.6% | – | −207.4% | −291.4% | −461.8% | −357.9% | −1,000.3% | −898.8% |
Earlier years, Mar 2008 to Mar 2012
| ₹ crore | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 |
|---|---|---|---|---|---|
| Revenue from operations | 208 | 244 | 342 | 397 | 223 |
| 169 | 202 | 284 | 352 | 214 | |
| Materials and goods bought | 84 | 108 | 169 | 198 | – |
| Employee costs | 9 | 10 | 12 | 16 | – |
| Other expenses | 76 | 85 | 102 | 139 | – |
| Operating profit before depreciation | 39 | 42 | 58 | 45 | 9 |
| Operating margin | 18.9% | 17.3% | 17.0% | 11.3% | 4.0% |
| Materials, % of revenue | 40.5% | 44.1% | 49.5% | 49.7% | – |
| Employee costs, % of revenue | 4.2% | 4.0% | 3.6% | 3.9% | – |
| Other expenses, % of revenue | 36.4% | 34.6% | 29.9% | 35.1% | – |
| Depreciation and amortisation | 4 | 6 | 6 | 8 | 13 |
| Operating profit after depreciation | 36 | 37 | 52 | 36 | −4 |
| Other income | 2 | – | – | – | – |
| Finance costs | 12 | 14 | 15 | 23 | 39 |
| Profit before tax | 25 | 23 | 37 | 14 | −43 |
| Tax | 3 | 3 | 10 | 5 | 5 |
| Net profit | 23 | 20 | 27 | 9 | −48 |
| Net margin | 10.9% | 8.2% | 7.8% | 2.2% | −21.5% |
Standalone, ₹ crore, years to March.
Balance sheet
Standalone, ₹ crore, at 31 March.
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|
| Net worth. What the company owns less everything it owes: the money shareholders have in the business, paid in and kept from profits. Net worth in the glossary | −108 | −447 | −562 | −683 | −824 |
| Share capitalShare capital. The face value of all the shares the company has issued. Share capital in the glossary | 30 | 30 | 30 | 30 | 30 |
| ReservesReserves. The rest of the shareholders' net worth: profits kept in the business over the years, and money paid for shares above their face value. Reserves in the glossary | −138 | −477 | −591 | −713 | −854 |
| Borrowings. Loans, bonds and other money the company has borrowed and must repay with interest. Borrowings in the glossary | 468 | 109 | 106 | 106 | 116 |
| Liabilities due within a year. Everything the company must pay within twelve months: borrowings falling due, suppliers, and other dues and provisions. Liabilities due within a year in the glossary | 531 | 878 | 1,006 | 1,144 | 1,201 |
| Liabilities due after a year. Everything the company owes that falls due more than twelve months on, borrowings among it. Liabilities due after a year in the glossary | 341 | 109 | 106 | 106 | 106 |
| Total assetsTotal assets. Everything the company owns or controls: plant, investments, stock, money owed by customers and cash. Total assets in the glossary | 764 | 539 | 550 | 567 | 483 |
| Assets held for longer than a year. Everything the company owns that it does not expect to turn into cash within twelve months: plant, intangibles, long-term investments, loans given and the like. Assets held for longer than a year in the glossary | 700 | 473 | 484 | 499 | 416 |
| Assets turning to cash within a year. Everything the company expects to turn into cash or use up within twelve months: stock, money owed by customers, cash and short-term investments. Assets turning to cash within a year in the glossary | 65 | 67 | 67 | 67 | 66 |
| Net debtNet debt. Borrowings less cash, other bank balances and current investments: what the company would still owe if it used its cash to repay. Net debt in the glossary | 468 | 108 | 106 | 106 | 108 |
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2013, Mar 2014, Mar 2015 and Mar 2017, so its lines and the ratios worked from it are blank there.
Cash flow
Standalone, ₹ crore, years to March.
| ₹ crore | Mar 2021 | Mar 2022 |
|---|---|---|
| Cash from operations. Cash the business brought in from its operations in the period, after paying suppliers, staff and tax. Cash from operations in the glossary | 125 | 0 |
| Change in working capital. Cash taken up, below nought, or released by the change in stock, money owed by customers, money owed to suppliers and other short-term items over the year. Change in working capital in the glossary | 137 | 14 |
| InventoriesChange in inventories. Cash taken up, below nought, or released by the change in stock held. Change in inventories in the glossary | 0 | 1 |
| PayablesChange in payables. Cash kept, above nought, or paid out by the change in what the company owes suppliers. Change in payables in the glossary | 0 | 2 |
| Other working capitalOther working capital. The working-capital change from every other short-term item: advances, provisions, other assets and liabilities. Other working capital in the glossary | 137 | 11 |
| Capital spendingCapital spending. Cash spent in the period on plant, equipment, buildings and other long-lived assets. Capital spending in the glossary | 0 | 0 |
| Free cash flowFree cash flow. Cash from operations less capital spending: what is left to repay borrowings, pay dividends or keep. Free cash flow in the glossary | 125 | 0 |
| Cash from investing. Cash spent on, below nought, or received from plant, investments, businesses bought or sold, and interest and dividends received. Cash from investing in the glossary | 0 | 65 |
| Cash from financing. Cash raised from, or paid to, lenders and shareholders: borrowings taken and repaid, interest, lease payments, dividends and shares issued or bought back. Cash from financing in the glossary | −125 | −64 |
| Dividends paidDividends paid. Cash paid to shareholders as dividends during the period. Dividends paid in the glossary | 0 | 0 |
| Shares bought backShares bought back. Cash spent buying the company's own shares back from shareholders. Shares bought back in the glossary | 0 | 0 |
| Shares issuedShares issued. Cash raised by selling new shares. Shares issued in the glossary | 0 | 0 |
| Net change in cashNet change in cash. Cash from operations, investing and financing added together: how much cash and cash equivalents rose or fell over the year, before currency effects. Net change in cash in the glossary | 0 | 0 |
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2017, Mar 2018, Mar 2019 and Mar 2020.
Ratios
Standalone, years to March.
| Ratio | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | −15.9% | −0.2% | −5.5% | – | – | – | −2.9% | −0.5% | −61.8% | −30.2% |
| Return on equity. Profit belonging to shareholders as a percentage of their average net worth over the year. | – | – | – | – | – | 89.2%what Return on equity, Mar 2018, includes. This year's return on equity, asset turnover and assets per rupee of net worth are on its year-end balance sheet: none a year before is on record to average with. | 53.3% | 22.6% | 19.6% | 10.1% |
| Change in return on equity. This year's return on equity less last year's, in percentage points, split below into what came from the margin, turnover and borrowing, which add up to it. Change in return on equity in the glossary | – | – | – | – | – | – | −35.9 pts | −30.7 pts | −3.1 pts | −9.4 pts |
| From the net marginChange from the net margin. The part of the change in return on equity that came from profit per rupee of sales. Change from the net margin in the glossary | – | – | – | – | – | – | 52.1 pts | −12.0 pts | 40.6 pts | −2.0 pts |
| From asset turnoverChange from asset turnover. The part of the change in return on equity that came from sales per rupee of assets. Change from asset turnover in the glossary | – | – | – | – | – | – | 19.7 pts | 7.9 pts | −39.7 pts | −4.5 pts |
| From borrowingChange from borrowing. The part of the change in return on equity that came from assets per rupee of net worth. Change from borrowing in the glossary | – | – | – | – | – | – | −107.6 pts | −26.6 pts | −4.0 pts | −2.9 pts |
| Return on capital employedReturn on capital employed. Operating profit after depreciation divided by net worth plus borrowings at the year end, times 100: what the business earns on all the money in it. | – | – | – | – | – | −9.5% | – | – | – | – |
| Receivable daysReceivable days. Trade receivables divided by revenue, times 365: the average days customers take to pay. Receivable days in the glossary | – | – | – | – | – | 632 | 0 | 0 | 0 | 0 |
| Inventory daysInventory days. Inventories divided by the cost of materials and goods, times 365: the days of stock the company holds. Inventory days in the glossary | – | – | – | – | – | 67 | 224 | 72 | 103 | 69 |
| Payable daysPayable days. Trade payables divided by the cost of materials and goods, times 365: the average days the company takes to pay suppliers. Payable days in the glossary | – | – | – | – | – | 733 | 671 | 458 | 503 | 71,855 |
| Cash conversion cycle, daysCash conversion cycle. Receivable days plus inventory days less payable days: how long money is tied up between paying suppliers and being paid by customers. Cash conversion cycle in the glossary | – | – | – | – | – | −34 | −446 | −385 | −401 | −71,786 |
| Working capital daysWorking capital days. Assets turning to cash within a year, less cash, bank deposits and current investments, minus liabilities due within a year, less borrowings, divided by the year's revenue, times 365. Working capital days in the glossary | – | – | – | – | – | −3,759what Working capital days, Mar 2018, includes. This year's balance sheet lists long-term loans due within the year among other liabilities, not borrowings, so its working capital days count them, unlike the years from April 2021. | −9,247what Working capital days, Mar 2019, includes. This year's balance sheet lists long-term loans due within the year among other liabilities, not borrowings, so its working capital days count them, unlike the years from April 2021. | −10,753what Working capital days, Mar 2020, includes. This year's balance sheet lists long-term loans due within the year among other liabilities, not borrowings, so its working capital days count them, unlike the years from April 2021. | −32,288what Working capital days, Mar 2021, includes. This year's balance sheet lists long-term loans due within the year among other liabilities, not borrowings, so its working capital days count them, unlike the years from April 2021. | −48,680 |
| Asset turnoverAsset turnover. Revenue divided by average total assets: rupees of sales for each rupee of assets. Asset turnover in the glossary | – | – | – | – | – | 0.04 | 0.05 | 0.06 | 0.02 | 0.02 |
| Assets per rupee of net worthAssets per rupee of net worth. Average total assets divided by average net worth: how far borrowings and other liabilities stretch the shareholders' money. Assets per rupee of net worth in the glossary | – | – | – | – | – | −7.09 | −2.35 | −1.08 | −0.90 | −0.70 |
| Sales per rupee of plantSales per rupee of plant. Revenue divided by the net block: rupees of sales for each rupee of plant in use. Sales per rupee of plant in the glossary | – | – | – | – | – | 0.05 | 0.09 | 0.09 | 0.04 | 0.04 |
| Capital spending to depreciationCapital spending to depreciation. Capital spending for the period divided by its depreciation and amortisation. Capital spending to depreciation in the glossary | – | – | – | – | – | – | – | – | 0.00 | 0.00 |
| Plant being built, % of plant in useCapital work in progress, % of net block. Plant still being built as a percentage of the plant in use. Capital work in progress, % of net block in the glossary | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% |
Interest cover is left blank for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2017, Mar 2018, Mar 2019, Mar 2020, Mar 2021 and Mar 2022: operating profit after depreciation is a loss, and a loss covers no interest bill. Debt to equity is left blank for the years to Mar 2018, Mar 2019, Mar 2020, Mar 2021 and Mar 2022: net worth is below zero, so there is no shareholders' money to set the borrowings against. Revenue growth is left blank for the year to Mar 2018: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. Return on capital employed is left blank for the years to Mar 2019, Mar 2020, Mar 2021 and Mar 2022: net worth and borrowings together come to nought or less, so there is no money employed to set the operating profit against. No balance sheet is on record for the years to Mar 2013, Mar 2014, Mar 2015 and Mar 2017, so its lines and the ratios worked from it are blank there.
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2022.
- Return on assets, latest yearReturn on assets, latest year. Profit to the company's own shareholders in the latest year ÷ the average of that year's opening and closing total assets × 100; empty for a bank, a lender or an insurer, whose own return on assets is shown with its accounts.
- −14.6%
| Measure | 10 years | 5 years | 3 years |
|---|---|---|---|
| Revenue growth, yearly rateRevenue growth, yearly rate. 3 years: Revenue in the latest year ÷ revenue in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Revenue in the latest year ÷ revenue in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Revenue in the latest year ÷ revenue in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | – | – | −35.7% |
| Return on equity, averageReturn on equity, average. 3 years: The plain average of the yearly return on equity over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly return on equity over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly return on equity over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | – | 39.0% | 17.4% |
| Operating margin, averageOperating margin, average. 3 years: The plain average of the yearly operating profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly operating profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly operating profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −55.0% | −84.5% | −106.5% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −369.5% | −602.0% | −752.3% |
| Asset turnover, averageAsset turnover, average. 3 years: The plain average of the yearly asset turnover over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly asset turnover over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly asset turnover over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | – | 0.04 | 0.03 |
| Cash conversion cycle, days, averageCash conversion cycle, days, average. 3 years: The plain average of the yearly cash conversion cycle in days over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly cash conversion cycle in days over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly cash conversion cycle in days over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | – | −14,610 | −24,191 |
Where the cash came from and went
Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2022.
| ₹ crore | Latest year |
|---|---|
| Cash from operationsCash from operations. Latest year: Cash from operating activities in the latest year. 3 years: Cash from operating activities added over the last three years, needing every one of them. 5 years: Cash from operating activities added over the last five years, needing every one of them. | −0.5 |
| Cash from investingCash from investing. Latest year: Cash from investing activities in the latest year. 3 years: Cash from investing activities added over the last three years, needing every one of them. 5 years: Cash from investing activities added over the last five years, needing every one of them. | 64.7 |
| Cash from financingCash from financing. Latest year: Cash from financing activities in the latest year. 3 years: Cash from financing activities added over the last three years, needing every one of them. 5 years: Cash from financing activities added over the last five years, needing every one of them. | −64.3 |
| Capital spendingCapital spending. Latest year: Spending on property, plant and equipment in the latest year. 3 years: Spending on property, plant and equipment added over the last three years, needing every one of them. 5 years: Spending on property, plant and equipment added over the last five years, needing every one of them. | 0.0 |
| Dividends paidDividends paid. Latest year: Dividends paid in the latest year. 3 years: Dividends paid added over the last three years, needing every one of them. 5 years: Dividends paid added over the last five years, needing every one of them. | 0.0 |
| Shares bought backShares bought back. Latest year: Shares bought back in the latest year. 3 years: Shares bought back added over the last three years, needing every one of them. 5 years: Shares bought back added over the last five years, needing every one of them. | 0.0 |
| Shares issued for cashShares issued for cash. Latest year: Shares issued for cash in the latest year. 3 years: Shares issued for cash added over the last three years, needing every one of them. 5 years: Shares issued for cash added over the last five years, needing every one of them. | 0.0 |
| Borrowings raisedBorrowings raised. Latest year: Money raised by borrowing, as a positive amount, in the latest year; empty where a year's filing states only borrowing net of repayment, which says neither how much was raised nor how much paid back. 3 years: Money raised by borrowing, as a positive amount, added over the last three years, needing every one of them; empty where a year's filing states only borrowing net of repayment, which says neither how much was raised nor how much paid back. 5 years: Money raised by borrowing, as a positive amount, added over the last five years, needing every one of them; empty where a year's filing states only borrowing net of repayment, which says neither how much was raised nor how much paid back. | 35.1 |
| Borrowings repaidBorrowings repaid. Latest year: Money paid back on borrowings, as a positive amount, in the latest year. 3 years: Money paid back on borrowings, as a positive amount, added over the last three years, needing every one of them. 5 years: Money paid back on borrowings, as a positive amount, added over the last five years, needing every one of them. Borrowings repaid in the glossary | 0.0 |
Business segments
In the year to Mar 2022 the company reports one business segment, Pharmaceuticals, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2022, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +14.3% | – | – | 0.0% |
| 3 years | −24.8% | – | – | 0.0% |
| 5 years | −33.2% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Who owns Parenteral Drug (India), filing by filing
Per cent of the company's shares. Every filing on record, from Sep 2021; the latest is the filing for Mar 2022.
| Per cent | Sep 2021 | Dec 2021 | Mar 2022 |
|---|---|---|---|
| 73.28% | 73.28% | 73.29% | |
| Indian promoters | 73.28% | 73.28% | 73.29% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 26.72% | 26.72% | 26.71% |
| Promoter shares pledgedShare of the promoters' own shares | 94.51% | 94.51% | 94.50% |
| Shares in issue | 2,98,16,300 | 2,98,16,300 | 2,98,16,300 |
Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state.
Parenteral Drug (India) promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Mar 2022; the largest is MVG Mercantile Private Limited, 32.61%.
| Holder | ||||
|---|---|---|---|---|
| MVG Mercantile Private LimitedIndian companies, trusts and others | 32.61% | 97,22,966 | 97,22,966 | 100.00% |
| Rajratan Exports Private LimitedIndian companies, trusts and others | 22.36% | 66,66,665 | 66,66,665 | 82.00% |
| PDPL Holdings Private LimitedIndian companies, trusts and others | 10.79% | 32,17,120 | 32,17,120 | 100.00% |
| Mahaganpati Investment Private LimitedIndian companies, trusts and others | 5.37% | 16,00,000 | 16,00,000 | 100.00% |
| PDPL Securities Private LimitedIndian companies, trusts and others | 2.05% | 6,11,506 | 6,11,506 | 100.00% |
| Parenteral Commercial Services Private LimitedIndian companies, trusts and others | 0.10% | 30,986 | 30,986 | 100.00% |
| Mr Anil MittalIndividuals and Hindu undivided familiesHindu undivided family. A family the tax law treats as one holder: property held in the family's name, shared by its members and managed by one of them. Hindu undivided family in the glossary | 0.01% | 1,600 | 0 | 0.00% |
| Mr. Anil MittalIndividuals and Hindu undivided families | 0.00% | 266 | 266 | 0.00% |
Pledged is the share of the holder's own shares pledged to a lender. In demat is the part of the holding kept electronically; the rest is paper certificates.
Largest public holders of Parenteral Drug (India), filing by filing
Per cent, on the same shares as the split above.
| Holder | Sep 2021 | Dec 2021 | Mar 2022 |
|---|---|---|---|
| Shitiz SehgalResident individuals, over ₹2 lakh at face value | 1.40% | 1.40% | 1.40% |
| Amax Network Pvt LtdOther non-institutions | 1.34% | 1.34% | 1.34% |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Parenteral Drug (India) dividend calendar
Each payment in the month it went ex, as declared, ₹ a share at the time. Years running counted to the year to Mar 2022.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | In the year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010 | ₹2.00 | Not added up | |||||||||||
| 2009 | ₹1.50 | ₹1.50 | |||||||||||
| 2008 | ₹1.50 | ₹1.50 | |||||||||||
| 2007 | ₹1.50 | Not added up |
Interim or final dividendSpecial dividendNone that month
Parenteral Drug (India) dividend history
Every payment with its ex-date and record date, year by year.
2010
- Sep13Mon
₹2.00FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary
Ex-date 13 Sep 2010 · books closed to 15 Sep 2010
0.64%of the price
2009
- Dec23Wed
₹1.50Dividend
Ex-date 23 Dec 2009 · books closed to 28 Dec 2009
1.25%of the price
2008
- Sep24Wed
₹1.50Final
Ex-date 24 Sep 2008 · books closed to 30 Sep 2008
1.99%of the price
2007
- Sep21Fri
₹1.50Final
Ex-date 21 Sep 2007 · books closed to 29 Sep 2007
0.81%of the price
Grouped by the calendar year each went ex, so a year's total here can differ from the year it was paid for above. Of the price is the dividend as a share of the close on the session before its ex-date. A book closure is the run of days the company's register is frozen to settle who is paid; a record date is the one-day form of it.
Parenteral Drug (India) share price by year
Each calendar year to 2023.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2023BSE close | 2.90 | −28.4% | 5.04 | 2.85 |
| 2022BSE close | 4.05 | +6.6% | 5.60 | 2.90 |
| 2021BSE close | 3.80 | +46.2% | 4.65 | 2.55 |
| 2020BSE close | 2.60 | −28.8% | 3.75 | 2.40 |
| 2019BSE close | 3.65 | −56.8% | 14.90 | 2.30 |
| 2018 | 8.45 | −66.9% | 25.65 | 7.50 |
| 2017 | 25.55 | +15.1% | 30.35 | 16.65 |
| 2016 | 22.20 | −52.8% | 77.40 | 19.90 |
| 2015 | 47.05 | +97.3% | 52.25 | 16.80 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2021 is from its first session, 1 Mar 2021. The close is the year's last trade for 2023 (21 Aug 2023) and 2020 (9 Mar 2020).
Recent sessions
The 10 trading days to 21 Aug 2023, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 21 Aug 2023 | 2.70 | 2.90 | 2.70 | 2.90 | 2.86 | 1,063 |
| 14 Aug 2023 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 | 10,190 |
| 7 Aug 2023 | 2.85 | 2.85 | 2.85 | 2.85 | 2.85 | 867 |
| 24 Jul 2023 | 3.05 | 3.05 | 2.90 | 3.00 | 3.01 | 2,475 |
| 17 Jul 2023 | 3.10 | 3.10 | 3.05 | 3.05 | 3.07 | 2,226 |
| 10 Jul 2023 | 3.30 | 3.30 | 3.20 | 3.20 | 3.28 | 6 |
| 3 Jul 2023 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 23 |
| 26 Jun 2023 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 80 |
| 19 Jun 2023 | 3.69 | 4.00 | 3.69 | 3.96 | 3.91 | 3,029 |
| 12 Jun 2023 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2,250 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 26 Jun 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 19 Jun 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 16 Jan 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 12 Jan 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 10 Jan 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 9 Jun 2022 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 6 Jun 2022 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 21 Feb 2022 | Price move | – | A corporate action went ex within three days of this move (E.G.M., ex-date 23 Feb 2022), and its terms do not account for the move. Not adjusted for. |
| 14 Feb 2022 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 26 Oct 2021 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 13 Sep 2010 | Bonus | 0.7500 | Holders received 1 bonus share for every 3 held. |
| 2 Nov 2007 | Bonus | 0.5000 | Holders received 1 bonus share for every 1 held. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout. Any other event is noted and not adjusted for.
Company details
- BSE code
- 524689
- ISIN
- INE904D01019
- Industry
- Pharmaceuticals & Biotechnology
- Former symbols
- PDPL
- Website
- www.pdindia.com
- CIN
- L24100MH1983PLC126481
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1983
- Registered office
- 340, Laxmi Plaza, Laxmi Industrial Estate, New Link Road, Andheri (W), Mumbai 400053, Maharashtra
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments